Literature DB >> 23933626

Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?

Patrick H Dessein1, Anne G Semb.   

Abstract

Entities:  

Keywords:  Cardiovascular Disease; Rheumatoid Arthritis; Treatment; Ultrasonography

Mesh：

Year:  2013        PMID： 23933626     DOI： 10.1136/annrheumdis-2013-203911

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.

Authors:  Chun Li; X R Wang; H J Ji; X Y Zhang; X F Li; L Z Wang; C H Wang; Y F Wang; Rong Yang; G C Wang; Xin Lu; Ping Zhu; L N Chen; H T Jin; J T Liu; X Y Liu; Lin Sun; H Y Chen; Ping Wei; J X Wang; L F Cui; Rong Shu; B L Liu; Z L Zhang; G T Li; Z B Li; Jing Yang; J F Li; Bin Jia; F X Zhang; J M Tao; S L Han; J Y Lin; M Q Wei; X M Liu; Dan Ke; S X Hu; Cong Ye; X Y Yang; Hao Li; C B Huang; Ming Gao; Bei Lai; X F Li; L J Song; Yi Wang; X Y Wang; Y D Tang; Yin Su; Rong Mu; Z G Li
Journal:  Clin Rheumatol       Date:  2017-03-24       Impact factor: 2.980

2.  Age impacts on the independent relationships of leptin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Patrick H Dessein; Gavin R Norton; Angela J Woodiwiss; Linda Tsang; Ahmed Solomon
Journal:  Rheumatol Int       Date:  2014-01-08       Impact factor: 2.631

3.  Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.

Authors:  Prashant Kaushik; Daniel H Solomon; Jeffrey D Greenberg; James T Anderson; George Reed; Ozlem Pala; Bahar Sumbul-Yuksel; Pooja Kadam; Joel M Kremer
Journal:  Clin Rheumatol       Date:  2015-08-05       Impact factor: 2.980

4.  Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study.

Authors:  Alfonso Corrales; Patrick H Dessein; Linda Tsang; Trinitario Pina; Ricardo Blanco; Carlos Gonzalez-Juanatey; Javier Llorca; Miguel A Gonzalez-Gay
Journal:  Arthritis Res Ther       Date:  2015-03-11       Impact factor: 5.156

5.  Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management.

Authors:  Patrick H Dessein; Anne G Semb; Miguel A González-Gay; Calin D Popa
Journal:  Biomed Res Int       Date:  2015-03-12       Impact factor: 3.411

6.  Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis.

Authors:  Patrick H Dessein; Hon-Chun Hsu; Linda Tsang; Aletta M E Millen; Angela J Woodiwiss; Gavin R Norton; Ahmed Solomon; Miguel A Gonzalez-Gay
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

7.  Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis.

Authors:  Patrick H Dessein; Ahmed Solomon; Angela J Woodiwiss; Gavin R Norton; Linda Tsang; Miguel A Gonzalez-Gay
Journal:  Mediators Inflamm       Date:  2013-12-21       Impact factor: 4.711

Review 8.  Cardiovascular disease risk amongst African black patients with rheumatoid arthritis: the need for population specific stratification.

Authors:  Ahmed Solomon; Linda Tsang; Angela J Woodiwiss; Aletta M E Millen; Gavin R Norton; Patrick H Dessein
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

9.  Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis.

Authors:  Patrick H Dessein; Linda Tsang; Gavin R Norton; Angela J Woodiwiss; Ahmed Solomon
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

10.  Adiponectin and atherosclerosis in rheumatoid arthritis.

Authors:  Patrick H Dessein; Linda Tsang; Ahmed Solomon; Angela J Woodiwiss; Aletta M E Millen; Gavin R Norton
Journal:  Mediators Inflamm       Date:  2014-06-04       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.